Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


                   Appointment of Certain Officers; Compensatory

Arrangements of Certain


                   Officers.


On March 4, 2021, The Carlyle Group Inc. (the "Company") issued a press release
announcing that effective March 8, 2021, Derica Rice will join the Board of
Directors of the Company as a Class II director. The appointment was approved by
the Company's Board of Directors on March 3, 2021.
Mr. Rice, age 56, served as executive vice president of CVS Health and President
of CVS Caremark, the pharmacy benefits management business of CVS Health, from
March 2018 to February 2020. Previously, he held various executive positions at
Eli Lilly and Company, most recently executive vice president of Global Services
and chief financial officer from 2006 to 2017. Mr. Rice is currently a director
of Bristol-Meyers Squibb Company, Target Corporation and The Walt Disney
Company. Mr. Rice received his Bachelor of Science degree in Electrical and
Electronics Engineering from Kettering University and an MBA from Indiana
University.
No action has been taken at this time with respect to Mr. Rice's committee
appointments.
Mr. Rice will receive the annual compensation we provide to non-employee
directors as described in the "Director Compensation" section of the Company's
Annual Report on Form 10-K for the year ended December 21, 2019, filed with the
Securities and Exchange Commission on February 12, 2020.
Item 7.01   Regulation FD Disclosure.


A copy of the Company's press release regarding the matters described above has
been furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Pursuant to General Instruction B.2 of Current Report on Form 8-K, the
information in Item 7.01 of this Current Report on Form 8-K, including the press
release attached hereto as Exhibit 99.1, shall not be deemed to be "filed" for
the purposes of Section 18 of the Securities Exchange Act of 1934, as amended,
or otherwise subject to the liabilities of that section. Furthermore, such
information shall not be incorporated by reference into any filing or other
document pursuant to the Securities Act of 1933, as amended, except as shall be
expressly set forth by specific reference in such filing or document.
Item 9.01   Financial Statements and Exhibits


(d) Exhibits
   Exhibit No.           Description
       99.1                P    res    s     Release, dated March 4, 2021.
       104               Cover Page Interactive Data File (embedded within

the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses